News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
Honoring the many lived experiences with Long COVID
RECOVER recognizes International Long COVID Awareness Day on March 15—a day established by the Long COVID community to increase visibility of the condition, share resources, and educate the public.
Feature
159 Results
159 Results
RECOVER-TLC to host next webinar March 26, 2026
NIH and FNIH leaders will share insights and answer questions about the progress being made on the first wave of RECOVER-TLC clinical trials.
Announcement
RECOVER-TLC opens expanded enrollment in REVERSE-LC clinical trial
Researchers at 17 study sites across the US will test a possible treatment to help improve thinking and memory problems and reduce fatigue for people who have Long COVID.
Announcement
RECOVER Research Update: March 2026
Recent RECOVER publications include findings about possible causes of and treatments for Long COVID.
Feature
Researcher leads studies using electronic health data to understand Long COVID in children
Dr. Suchitra Rao’s expertise helps RECOVER’s electronic health record (EHR) and observational studies make important discoveries about Long COVID in children.
Feature
First results from RECOVER-AUTONOMIC clinical trials to be shared at upcoming conference
Results from the RECOVER-AUTONOMIC Moderate POTS (Ivabradine) clinical trial will be presented at an upcoming session of the American College of Cardiology (ACC) Annual Conference on March 28, 2026.
Announcement
R3 Seminar Recap: Long COVID trajectories in adults
During the February 10, 2026, RECOVER Research Review (R3) Seminar, RECOVER researchers Sarah Donohue, PhD, MPH, and Tanayott (Tony) Thaweethai, PhD, presented research on Long COVID trajectories in adults. Published in November 2025, this research—which includes participants from the initiative’s adult observational cohort study—explores different clinical presentations of Long COVID and how the condition progresses over time. RECOVER Patient Representative and co-author Mady Hornig, MD, MA, and Timothy Henrich, MD, MMSc, a Long COVID researcher, also shared their perspectives and experiences.
R3 Seminar Recap
RECOVER-TLC seeks input on planned study of possible Long COVID treatment
A public comment period will allow patients, caregivers, and researchers to comment on a study to test whether stellate ganglion nerve block (SGB) can help improve Long COVID symptoms.
Announcement
5 years in, RECOVER continues to advance its patient-centered mission
RECOVER marks 5 years of Long COVID research, with NIH leaders, scientists, and clinicians continuing to guide and advance the initiative’s mission. In 2026, RECOVER will expand clinical trials to find answers for the Long COVID community.
News Release